Which weight loss injections are affected by this change?
The following GLP-1 injections will no longer be covered for weight loss in 2026:
- Saxenda®
- Wegovy™
- Zepbound™
Can I request an exception or appeal to have my patient covered?
No, we are not making exceptions and coverage cannot be appealed because these drugs will be an exclusion to the member’s coverage and not part of their covered benefits. We will only cover GLP-1s for weight loss if the member’s employer purchases a rider to continue coverage.
My patient has an approved authorization beyond their renewal date. Will they have a grace period?
No, their authorization will expire upon their plan’s renewal date. For example, if the member has an authorization in place until March 1, 2026, and their plan renews on January 1, 2026, their authorization will expire on January 1, 2026.
When will my patients experience this change?
It depends on when their health plan benefits renew. For many of our members, this change will happen on January 1, 2026.
What will happen when a member still has coverage through a rider?
Members who will still have coverage will have to meet the clinical criteria and obtain prior authorization for the medication.